Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Observational study suggests use of statins lowers risk of advanced prostate cancer

19.04.2005


Use of such cholesterol-lowering drugs as statins may reduce the risk of advanced prostate cancer, according to research that followed 34,428 U.S. men for more than a decade.



The study, presented at the 96th Annual Meeting of the American Association for Cancer Research, found that men who used these medications had half the risk of advanced prostate cancer and a third of the risk of metastatic or fatal prostate cancer, compared to men who did not use cholesterol-lowering drugs. Risk of advanced prostate cancer fell with increasing duration of use of the drugs. The study did not find that use of cholesterol-lowering drugs had any influence on prostate cancer that is confined within the organ.

But while the researchers, from Johns Hopkins University, the National Cancer Institute and Harvard University, say that the magnitude of the inverse association between use of cholesterol-lowering drugs and advanced prostate cancer is impressive, they stress that confirmatory studies are needed.


"This is a very interesting and promising lead on a class of drugs that may be offering benefits that were not anticipated, but we need to replicate the findings in other large prospective studies as well as figure out the mechanisms at work," says lead investigator Elizabeth Platz, Sc.D., M.P.H., an assistant professor at the Johns Hopkins Bloomberg School of Public Health.

"If the conclusions continue to hold up over time, there is great translational potential for preventing invasive and metastatic prostate cancer," she says. The researchers believe most of the protective effect they observed comes from statins, rather than other types of cholesterol-lowering drugs, because by 2000 more than 90 percent of the men who reported that they were using cholesterol-lowering drugs said that they were using statins, in particular. The researchers also say they don’t know whether the apparent benefit of statins is due to their cholesterol-lowering effect or their other properties, such as their anti-inflammatory activity or their effects on post-translational modification of proteins.

The work was conducted in the Health Professionals Follow-up Study, an ongoing, large prospective cohort study that began at the Harvard School of Public Health in 1986. The few other studies that have looked at use of statins and development of prostate cancer have shown mixed results.

This study is unique, Platz says, because of its size, that the use of the drugs was determined before the diagnosis of prostate cancer, and because it examined associations based on stage of the disease. All of the 34,438 participants were free of a prostate cancer diagnosis in 1990, but by 2000, 2,074 men were diagnosed with prostate cancer. Of these, 283 were advanced, and within this subgroup, 206 were metastatic or fatal.

"We are excited by these initial findings, which may motivate more basic, clinical, and epidemiologic research into what appears to be a very promising area for prostate cancer," Platz says.

Warren R. Froelich | EurekAlert!
Further information:
http://www.aacr.org

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Challenging European Research Project to Develop New Tiny Microscopes

The Institute of Semiconductor Technology and the Institute of Physical and Theoretical Chemistry, both members of the Laboratory for Emerging Nanometrology (LENA), at Technische Universität Braunschweig are partners in a new European research project entitled ChipScope, which aims to develop a completely new and extremely small optical microscope capable of observing the interior of living cells in real time. A consortium of 7 partners from 5 countries will tackle this issue with very ambitious objectives during a four-year research program.

To demonstrate the usefulness of this new scientific tool, at the end of the project the developed chip-sized microscope will be used to observe in real-time...

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Transport of molecular motors into cilia

28.03.2017 | Life Sciences

A novel hybrid UAV that may change the way people operate drones

28.03.2017 | Information Technology

NASA spacecraft investigate clues in radiation belts

28.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>